12:00 AM
Oct 01, 2012
 |  BC Week In Review  |  Company News  |  Deals

Curetis, Heraeus Medical deal

Curetis and Heraeus partnered to jointly develop a Unyvero cartridge to detect pathogens and antibiotic resistances in implant and tissue infections. The companies will co-fund development and said orthopedics would be a key application area. There are no licenses involved...

Read the full 179 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >